I was reading on another forum that from the beginning of next year, pharmacists will be expected to substitute brand named prescriptions for generic equivalents without consulting with doctors or patients in an effort to cut costs.
Obviously in many cases, generic and branded are the same, but there can be differences and this can have implications. Does anyone know much about this and how it will apply to/impact on people with asthma?
For instance, will we automatically be changed from Ventolin inhalers to those horrid little blue ones (I use this as an example because it's one where I feel there is a difference and that the little ones don't give me the relief the Ventolin inhalers do)?
I could have got this completely wrong BTW and would be happy to be corrected!!